ChristopherDO'BrienMDPhD
Pulmonology • Lafayette Hill, PACritical Care Medicine
Chief Medical Officer Kinaset Therapeutics
Dr. O'Brien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Chinaberry Dr
Lafayette Hill, PA 19444
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998- University of Pennsylvania Health SystemResidency, Internal Medicine, 1991 - 1994
Uconn School Of MedicineClass of 1991
Certifications & Licensure
PA State Medical License 1993 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 7 citationsEfficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with ast...James Zangrilli, Lyndon E. Mansfield, Tom Uryniak, C.D. O'Brien
Annals of Allergy, Asthma & Immunology. 2011-09-01 - 53 citationsRole of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration.Christopher D. O'Brien, Gaoyuan Cao, Antonis Makrigiannakis, Horace M. DeLisser
American Journal of Physiology. Cell Physiology. 2004-06-16 - 52 citationsPECAM-1–dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localizationChristopher D. O'Brien, Poay Lim, Jing Sun, Steven M. Albelda
Blood. 2003-04-01
Journal Articles
- Model‐Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti–Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn D...Jie Zhou PhD, Yan Xu MD, PhD, FCP, Yang Chen PhD, Jie Shao PhD, Yaming Su PhD, Zhenhua Xu MD, PhD, FCP, Honghui Zhou PhD, FCP, FAAPS, Christopher O'Brien PhD, MD, The Journal of Clinical Pharmacology, 5/17/2023
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative ColitisBruce E. Sands, M.D. https://orcid.org/0000-0001-5762-5042, William J. Sandborn, M.D., Remo Panaccione, M.D., Christopher D. O’Brien, M.D., Ph.D., Hongyan Zhang, Ph.D...., NEJM, 9/25/2019
Grant Support
- Mechanisms Of PECAM-1 Signaling In Endothelial CellsNational Heart, Lung, And Blood Institute2000–2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
